Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection

CONCLUSION: High comorbidity burden was associated with primary treatment choice, with significantly less RP and more EBRT, WW and ADT alone among men with higher levels of comorbidity. Each of the individual comorbid conditions also influenced treatment selection.PMID:38369388 | DOI:10.1016/j.clgc.2024.01.018

Source: Clinical Prostate Cancer - February 18, 2024 Category: Cancer & Oncology Authors: Tenaw Tiruye Michael O'Callaghan Liesel M FitzGerald Kim Moretti Alex Jay Braden Higgs Ganessan Kichenadasse Gillian Caughey David Roder Kerri Beckmann Source Type: research